Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
ACTIVE
Global HQ
United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Media
  • Entertainment
  • Health Tech
  • Fintech
  • Mobile
  • Retail Tech
About
The Column Group is a science-driven venture capital firm that invests in early-stage biotechnology companies, focusing on building drug discovery enterprises that leverage unique scientific platforms to develop breakthrough therapeutics.
Min check size
$5M
Max check size
$50M
Fund size
NPS

Investment Thesis

TCG is a sciencedriven venture capital firm that invests in early stage drug discovery companies with unique scientific platforms that can deliver breakthrough therapeutics.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

With extensive experience in private equity, the fund manager has successfully executed over 50 transactions across various sectors, including technology, healthcare, and consumer goods. Their strategic approach emphasizes operator-first investments, prioritizing management capabilities to drive growth. Active primarily in North America and Europe, they have achieved notable exits that underline their expertise in identifying high-potential companies at the growth stage. Their data-driven analysis informs investment decisions, allowing for a thematic focus that aligns with emerging market trends.

The Column Group Contacts Information

Primary contact

Secondary contact

Team

Peter Svennilson

Jj Kang

James Evangelista

Adriana Tajonar

Timothy Kutzkey

Tim Kutzkey

Sue Murakami

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp